Insomnia
Conditions
Brief summary
SLEEP-4-ALL-1 is a pilot and ecological study corresponding to the developpement phase of a randomized controlled multicentric trial SLEEP-4-ALL-2. The main objective of this second study will be the validation of a stepped-care model in the treatment of persistant insomnia in cancer patients. The primary objective of SLEEP-4-ALL-1 is to determine the acceptability of a self-screening for insomnia in cancer outpatients at Gustave Roussy.
Interventions
OTHERQuestionnaires
To patients who have given their consent for the self-screening, the research assistant will propose 3 questionnaires, which will be completed in the waiting room and returned the same day: * Ad hoc questionnaire for demographics and medical data; * Insomnia Severity Index (ISI, 7 items, Savard et al., 2005); * Edmonton Symptom Assessment System (ESAS, 10 items, Visual Analogue Scale, Bruera et al. 1991) assessing comorbidities as pain, dyspnea, anxiety or depression... The ISI scoring will be realized by the research assistant (in the research office) immediately after its completion.
Sponsors
Gustave Roussy, Cancer Campus, Grand Paris
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
1. Adults outpatients at Gustave Roussy, 2. with a breast, colorectal, pulmonary or urological, 3. localized or metastatic cancer, 4. during or after their treatment, 5. able to readily read and understand French, 6. able to use informatic tools confidently and with Internet access at home, 7. who have signed a written informed consent form prior to any study specific procedures, 8. affiliated to a social security system or beneficiary of the same.
Exclusion criteria
1. Age \> 85 years old, 2. patient receiving a cancer diagnostic during a consultation of announcement 3. with a WHO index of 3 or 4 4. severe cognitive impairements or psychiatric disorders which are incompatible with the conditions and the conduct of the study (understanding of the objectives, completion of the questionnaires) 5. simultaneous participation in another study of the same type 6. patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acceptance rate of self-screening for insomnia | Up to 8 weeks |
Countries
France
Outcome results
None listed